Method and composition for treating mammalian diseases and injuries caused by the over-expression of peroxynitrite

Details for Australian Patent Application No. 2006213755 (hide)

Owner North Cell Pharmaceutical

Inventors Martin, Alain

Agent Shelston IP

Pub. Number AU-B-2006213755

PCT Pub. Number WO2006/086643

Priority 11/056,759 11.02.05 US

Filing date 10 February 2006

Wipo publication date 17 August 2006

Acceptance publication date 11 August 2011

International Classifications

A61K 45/00 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61K 31/19 (2006.01)

A61K 31/20 (2006.01)

A61K 31/56 (2006.01) - Compounds containing cyclopenta[a]hydrophenanthrene ring systems

A61K 38/43 (2006.01) Medicinal preparations containing peptides - Enzymes

Event Publications

2 August 2007 PCT application entered the National Phase

  PCT publication WO2006/086643 Priority application(s): WO2006/086643

11 August 2011 Application Accepted

  Published as AU-B-2006213755

8 December 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006213760-Treatment for topical use alleviating or inhibiting joint pain or muscle pain or musculoskeletal pain in a mammal

2006213746-Oxime and hydroxylamine substituted imidazo(4,5-c) ring compounds and methods